Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients - Chen, C. (China International Cooperation Center for Environment and Human Health. Nanjing Medical University) ; Wei, Y. (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Wei, Liangmin (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Chen, J. (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Chen, X. (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Dong, X. (Department of Epidemiology and Biostatistics. School of Public Health. Southeast University) ; He, J. (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Lin, L. (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Zhu, Y. (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Huang, H. (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; You, D. (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Lai, L. (Department of Biostatistics. Center for Global Health. School of Public Health. Nanjing Medical University) ; Shen, S. (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Duan, W. (Department of Bioinformatics. School of Biomedical Engineering and Informatics. Nanjing Medical University) ; Su, L. (Department of Environmental Health. Harvard T.H. Chan School of Public Health) ; Shafer, A. (Harvard Medical School) ; Fleischer, T. (Department of Cancer Genetics. Institute for Cancer Research. Oslo University Hospital) ; Bjaanæs, Maria Moksnes (Department of Cancer Genetics. Institute for Cancer Research. Oslo University Hospital) ; Karlsson, A. (Division of Oncology and Pathology. Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research. Lund University) ; Planck, M. (Division of Oncology and Pathology. Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research. Lund University) ; Wang, R. (Department of Medical Oncology. Jinling Hospital. School of Medicine. Nanjing University) ; Staaf, J. (Division of Oncology and Pathology. Department of Clinical Sciences Lund and CREATE Health Strategic Center for Translational Cancer Research. Lund University) ; Helland, Å. (Institute of Clinical Medicine. University of Oslo) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zhang, R. (Department of Medical Oncology. Jinling Hospital. School of Medicine. Nanjing University) ; Chen, F. (Jiangsu Key Lab of Cancer Biomarkers. Prevention and Treatment. Cancer Center. Collaborative Innovation Center for Cancer Personalized Medicine. Nanjing Medical University) ; Christiani, David C (Harvard Medical School) ; Universitat Autònoma de Barcelona